GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
H

Hanmi Pharm Co 128940.KS · KRW

Health Care · KRX · 🇰🇷 South Korea

Compare

475,000

+1.71%

Close of 9 Nov 2026, in KRW

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in KRW, from our data supplier.

FY2025

Revenue

₩1.55trn

FY2016FY2025

Net income

₩169.55bn

FY2016FY2025

Free cash flow

₩96.53bn

FY2016FY2025

Shareholders' equity

₩1.25trn

FY2016FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue₩1.55trn₩1.50trn₩1.49trn₩1.33trn₩1.20trn₩1.08trn₩1.11trn₩1.02trn₩916.59bn₩882.72bn
Gross profit₩884.41bn₩817.04bn₩829.25bn₩718.55bn₩632.75bn₩580.92bn₩632.48bn₩540.92bn₩518.40bn₩460.86bn
Research and development₩195.83bn₩178.89bn₩181.77bn₩154.32bn₩146.03bn₩212.39bn₩194.29bn₩165.91bn₩151.29bn₩142.89bn
Operating income₩257.80bn₩216.19bn₩224.88bn₩158.09bn₩125.42bn₩48.98bn₩125.34bn₩83.57bn₩82.16bn₩26.77bn
Net income₩169.55bn₩121.32bn₩146.23bn₩82.79bn₩67.03bn₩11.96bn₩52.11bn₩24.89bn₩60.43bn₩23.33bn
Diluted earnings per share14,689.8210,510.4812,669.157,172.905,806.931,036.124,514.672,112.604,189.901,974.30

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Total assets₩2.14trn₩2.02trn₩1.90trn₩1.92trn₩1.94trn₩1.88trn₩1.91trn₩1.69trn₩1.66trn₩1.60trn
Total liabilities₩714.74bn₩780.09bn₩798.46bn₩915.36bn₩1.01trn₩1.05trn₩1.09trn₩901.95bn₩868.51bn₩862.45bn
Debt—₩496.69bn₩572.87bn₩678.32bn₩703.64bn₩802.19bn₩851.57bn₩631.19bn₩476.24bn₩332.22bn
Shareholders' equity₩1.25trn₩1.08trn₩955.44bn₩871.87bn₩802.91bn₩729.99bn₩723.80bn₩703.23bn₩711.71bn₩659.46bn
Shares outstanding12m12m12m12m12m12m12m12m14m12m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations₩173.07bn₩193.49bn₩216.54bn₩162.27bn₩201.92bn₩151.53bn₩12.45bn₩25.98bn−₩62.91bn₩412.97bn
Capital spending−₩76.55bn−₩62.55bn−₩43.74bn−₩30.38bn−₩19.95bn−₩41.82bn−₩166.13bn−₩182.27bn−₩247.05bn−₩224.09bn
Free cash flow₩96.53bn₩130.93bn₩172.80bn₩131.89bn₩181.97bn₩109.72bn−₩153.68bn−₩156.29bn−₩309.96bn₩188.87bn
Dividends paid−₩30.86bn−₩12.56bn−₩18.00bn−₩5.99bn−₩5.88bn−₩8.14bn−₩5.66bn−₩8.96bn−₩8.96bn−₩20.42bn

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
Revenue₩467.25bn₩392.93bn₩432.96bn₩362.35bn₩361.28bn₩390.95bn₩351.61bn₩362.08bn
Gross profit₩303.21bn₩217.29bn₩260.48bn₩205.59bn₩204.74bn₩213.59bn₩185.24bn₩198.63bn
Operating income₩131.09bn₩56.16bn₩83.27bn₩55.07bn₩52.41bn₩59.02bn₩30.46bn₩50.98bn
Net income₩83.31bn₩45.49bn₩48.12bn₩40.13bn₩38.70bn₩42.61bn−₩4.95bn₩31.00bn
Diluted earnings per share7,217.833,941.184,168.643,476.653,353.273,691.26-429.252,685.50
Cash from operations₩104.72bn₩111.64bn₩14.51bn₩42.02bn₩37.20bn₩79.34bn₩14.76bn₩20.03bn
Capital spending−₩28.27bn−₩18.64bn−₩27.72bn−₩15.95bn−₩19.70bn−₩13.18bn−₩21.52bn−₩11.51bn
Free cash flow₩76.45bn₩93.00bn−₩13.21bn₩26.07bn₩17.49bn₩66.17bn−₩6.77bn₩8.52bn
Total assets₩2.33trn₩2.23trn₩2.14trn₩2.04trn₩1.96trn₩1.98trn₩2.02trn₩1.97trn
Debt₩90.94bn₩91.38bn₩91.81bn₩92.70bn₩74.59bn₩80.22bn₩85.86bn₩91.50bn
Shareholders' equity₩1.40trn₩1.30trn₩1.25trn₩1.18trn₩1.13trn₩1.11trn₩1.08trn₩1.08trn

Growth per year

Compound annual rate

3 years5 years10 years
Revenue5.1%7.5%1.6%
Operating income17.7%39.4%2.0%
Net income27.0%69.9%0.9%

Average margins

Over each period

1 year3 years5 years10 years
Gross margin55.9%55.4%54.8%56.3%
Operating margin15.6%14.6%12.7%11.7%
Net margin9.6%8.9%7.4%6.8%

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Price to earnings30.826.727.840.745.7333.360.7198.9123.8125.9
Price to sales3.42.22.72.52.53.72.84.98.23.3

Dividends and splits

Per share, in the currency the company pays

Paid for 0 years. Last went ex-dividend on 30 Mar 2026.

FY2026FY2024FY2023FY2022FY2021FY2020FY2019FY2018
Paid in the year2,000.001,750.00490.196480.584471.161452.865452.865443.986
  • 1.02-for-1 split · 27 Dec 2023
  • 51-for-50 split · 28 Dec 2022
  • 51-for-50 split · 29 Dec 2021
  • 1.02-for-1 split · 29 Dec 2020
  • 1.02-for-1 split · 27 Dec 2019
  • 1.02-for-1 split · 27 Dec 2018

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.